CureVac Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CVAC?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	0	0%
Individual Insiders	212,981	0.0946%
Institutions	20,243,799	8.99%
General Public	204,724,867	90.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 7.71% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
2.02%	Glazer Capital, LLC	4,546,634	US$21.9m	664%	1.24%
1.02%	Alpine Associates Management Inc.	2,295,422	US$11.1m	16.5%	0.97%
0.76%	Qube Research & Technologies Ltd	1,712,737	US$8.3m	44.9%	0.01%
0.45%	BlackRock, Inc.	1,016,297	US$4.9m	-1.36%	no data
0.44%	AQR Capital Management, LLC	991,688	US$4.8m	2,150%	no data
0.34%	Water Island Capital, LLC	762,138	US$3.7m	-20.4%	0.77%
0.29%	Magnetar Capital Partners, LP	654,796	US$3.2m	0%	0.04%
0.22%	RBC Dominion Securities Inc.	500,598	US$2.4m	52,200%	no data
0.21%	Bridgewater Associates, LP	466,407	US$2.2m	0%	0.01%
0.19%	Bank of America Corporation	428,481	US$2.1m	899%	no data
0.18%	UBS Asset Management AG	401,269	US$1.9m	-9.51%	no data
0.18%	The Goldman Sachs Group, Inc.	399,893	US$1.9m	2.11%	no data
0.16%	Northern Trust Global Investments	354,694	US$1.7m	-9.53%	no data
0.15%	BNP Paribas Financial Markets SNC	330,515	US$1.6m	30.4%	no data
0.13%	JPMorgan Chase & Co.	301,398	US$1.5m	-3.88%	no data
0.12%	CSS, LLC	273,495	US$1.3m	0%	0.26%
0.11%	New York Life Investment Management LLC	258,116	US$1.2m	0%	0.01%
0.11%	Deutsche Asset & Wealth Management	254,725	US$1.2m	19.1%	no data
0.1%	Carmignac Gestion SA	235,180	US$1.1m	172%	0.01%
0.1%	Geode Capital Management, LLC	226,497	US$1.1m	-8%	no data
0.096%	Citigroup Inc.	216,875	US$1.0m	352%	no data
0.092%	Morgan Stanley	207,540	US$1.0m	72.8%	no data
0.086%	Schweizerische Nationalbank	193,579	US$933.1k	0%	no data
0.082%	Amundi Asset Management SAS	183,856	US$886.2k	34.4%	no data
0.069%	Forsta AP-fonden	156,252	US$753.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/17 07:55
End of Day Share Price	2025/12/17 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CureVac N.V. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Alec Stranahan	BofA Global Research
Douglas Buchanan	Citizens JMP Securities, LLC
Emmanuel Papadakis	Deutsche Bank